Tissue factor pathway inhibitor reduces experimental lung metastasis of B16 melanoma

Thrombosis and Haemostasis

Volumn 87, Issue 6, 2002, Pages 930-936

  Amirkhosravi, Ali ^a   Meyer, Todd ^a   Chang, Jen Yea ^a   Amaya, Mildred ^a   Siddiqui, Farooq ^a   Desai, Hina ^a   Francis, John L ^a  

^a FLORIDA HOSPITAL CANCER INSTITUTE   (United States)

Author keywords

Coagulation; Melanoma; Metastasis; TFPI; Tumor

Indexed keywords

RECOMBINANT TISSUE FACTOR PATHWAY INHIBITOR; THROMBOPLASTIN; TISSUE FACTOR PATHWAY INHIBITOR; ANTICOAGULANT AGENT; ENDOTHELIAL CELL GROWTH FACTOR; HEPARIN; LIPOPROTEIN; LIPOPROTEIN-ASSOCIATED COAGULATION INHIBITOR; LYMPHOKINE; SIGNAL PEPTIDE; VASCULOTROPIN; VASCULOTROPIN A;

ANGIOGENESIS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTICOAGULANT THERAPY; ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER GROWTH; CARCINOGENESIS; CONTROLLED STUDY; DRUG EFFICACY; EXPERIMENTAL NEOPLASM; EXPRESSION VECTOR; FEMALE; GENETIC TRANSFECTION; LUNG METASTASIS; MELANOMA B16; MOUSE; NONHUMAN; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; SOMATIC CELL; THROMBOCYTOPENIA; ANIMAL; C57BL MOUSE; DRUG EFFECT; EXPERIMENTAL MELANOMA; INTRAVENOUS DRUG ADMINISTRATION; LUNG TUMOR; METASTASIS; PATHOLOGY; SECRETION; THROMBOCYTE COUNT; THROMBOPHILIA;

ANIMALS; ANTICOAGULANTS; ENDOTHELIAL GROWTH FACTORS; FEMALE; HEPARIN; INJECTIONS, INTRAVENOUS; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; LIPOPROTEINS; LUNG NEOPLASMS; LYMPHOKINES; MELANOMA, EXPERIMENTAL; MICE; MICE, INBRED C57BL; NEOPLASM METASTASIS; PLATELET COUNT; THROMBOCYTOPENIA; THROMBOPHILIA; TRANSFECTION; VASCULAR ENDOTHELIAL GROWTH FACTOR A; VASCULAR ENDOTHELIAL GROWTH FACTORS;

EID: 0036285816     PISSN: 03406245     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-0037-1613114     Document Type: Article

References (31)

1. The coagulation explosion
2. Tissue factor pathway inhibitor and the revised theory of coagulation
3. Extrinsic pathway inhibitor - The key to feedback control of blood coagulation initiated by tissue thromboplastin
4. Plasma antigen levels of the lipoprotein-associated coagulation inhibitor in patient samples
5. Heparin/low molecular weight heparin and tissue factor pathway inhibitor
6. Cellular effects of heparin on the production and release of tissue factor pathway inhibitor in human endothelial cells in culture
7. Tissue factor pathway inhibitor in endothelial cells colocalizes with glycolipid microdomains/caveolae - Regulatory mechanism(s) of the anticoagulant properties of the endothelium
8. Thrombin induces the redistribution and acute release of tissue factor pathway inhibitor from specific granules within human endothelial cells in culture
9. Structural mechanism of heparin binding of the third Kunitz domain of tissue factor pathway inhibitor
10. The role of the C-terminal domain in the inhibitory functions of tissue factor pathway inhibitor
11. Hemostasis and malignancy
12. Venous thromboembolism in malignancy and malignancy in venous thromboembolism
13. Clotting factors in tumour tissue: Implications for cancer therapy
14. Animal tumor procoagulants: Registry of the Subcommittee on Haemostasis and Malignancy of the Scientific and Standardization Committee, International Society of Thrombosis and Haemostasis
15. Human tumor procoagulants: Registry of the Subcommittee of Haemostasis of the Scientific and Standardization Committee, International Society on Thrombosis and Haemostasis
16. Expression of tissue factor by melanoma cells promotes efficient hematogenous metastasis
17. Requirement for binding of catalytically active factor VIIa in tissue factor-dependent experimental metastasis
18. Abnormalities of blood coagulation in patients with cancer. Fibrinopeptide A generation and tumor growth
19. In situ detection of tissue factor in vascular endothelial cells: Correlation with the malignant phenotype of human breast disease
20. Distribution of tissue factor pathway inhibitor in normal and malignant human tissues
21. Cloning, expression, and characterization of mouse tissue factor pathway inhibitor (TFPI)
22. Platelet protective anticoagulants improve the reproducibility of the Sonoclot Analyzer
23. Isolation of the tissue factor inhibitor produced by HepG2 hepatoma cells
24. Oral anticoagulation in the treatment of a spontaneously metastasising murine tumor (3LL)
25. Coagulation activation by MC28 fibrosarcoma cells facilitates lung tumor formation
26. The effect of antibody against vascular endothelial growth factor on tumor growth and metastasis
27. Anti-VEGF antibody suppresses primary tumor growth and metastasis in an experimental model of Wilms' tumor
28. Isolation and characterisation of antistatin. An inhibitor of metastasis and coagulation
29. Tissue factor-initiated thrombin generation activates the signaling thrombin receptor on malignant melanoma cells
30. M. Ancylostoma caninum anticoagulant peptide blocks metastasis in vivo and inhibits factor Xa binding to melanoma cells in vitro
31. Several murine metastasizing tumors possess a cysteine proteinase with cancer procoagulant characteristics